Cargando…

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression

Detalles Bibliográficos
Autores principales:	Concha‐Marambio, Luis, Farris, Carly M., Holguin, Bret, Ma, Yihua, Seibyl, John, Russo, Marco J., Kang, Un J., Hutten, Samantha J., Merchant, Kalpana, Shahnawaz, Mohammad, Soto, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530949/ https://www.ncbi.nlm.nih.gov/pubmed/34236720 http://dx.doi.org/10.1002/mds.28715

Ejemplares similares

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
por: Russo, Marco J., et al.
Publicado: (2021)

Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
por: Russo, Marco J., et al.
Publicado: (2021)

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays
por: Bellomo, Giovanni, et al.
Publicado: (2023)

Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease
por: Kang, Un Jung, et al.
Publicado: (2019)

Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error rates
por: Middleton, John Stephen, et al.
Publicado: (2023)

Preclinical Detection of Prions in Blood of Nonhuman Primates Infected with Variant Creutzfeldt-Jakob Disease
por: Concha-Marambio, Luis, et al.
Publicado: (2020)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
por: Kaasinen, Valtteri
Publicado: (2015)

A dopaminergic deficit hypothesis of schizophrenia: the path to discovery
por: Carlsson, Arvid, et al.
Publicado: (2006)

Color naming deficits and attention-deficit/hyperactivity disorder: A retinal dopaminergic hypothesis
por: Tannock, Rosemary, et al.
Publicado: (2006)

Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo
por: Urayama, Akihiko, et al.
Publicado: (2016)

Theory of mind deficits in Parkinson’s disease are not modulated by dopaminergic medication
por: Usnich, Tatiana, et al.
Publicado: (2023)

Treatment with a Non-toxic, Self-replicating Anti-prion Delays or Prevents Prion Disease In vivo
por: Diaz-Espinoza, Rodrigo, et al.
Publicado: (2017)

Deficits in Sustained Attention and Changes in Dopaminergic Protein Levels following Exposure to Proton Radiation Are Related to Basal Dopaminergic Function
por: Davis, Catherine M., et al.
Publicado: (2015)

Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)
por: Suwijn, Sven R., et al.
Publicado: (2020)

Frontotemporal Lobe Degeneration as Origin of Scans Without Evidence of Dopaminergic Deficit
por: Menéndez-González, Manuel, et al.
Publicado: (2018)

Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice
por: Xu, Shuang-Feng, et al.
Publicado: (2018)

Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment
por: Ye, Jiaen, et al.
Publicado: (2019)

Sniffing out cognitive decline in patients with and without evidence of dopaminergic deficit
por: Lopez, Francesca V., et al.
Publicado: (2019)

Exercise Ameliorates Motor Deficits and Improves Dopaminergic Functions in the Rat Hemi-Parkinson’s Model
por: Chen, Yuan-Hao, et al.
Publicado: (2018)

Development of a methodology for large-scale production of prions for biological and structural studies
por: Concha-Marambio, Luis, et al.
Publicado: (2023)

The Future of Seed Amplification Assays and Clinical Trials
por: Coysh, Thomas, et al.
Publicado: (2022)

Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit
por: Langley, Jason, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
por: Jung, Un Ju, et al.
Publicado: (2014)

Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
por: Stockner, Heike, et al.
Publicado: (2012)

Decreased NAD+ in dopaminergic neurons
por: Sison, Samantha L., et al.
Publicado: (2018)

Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo
por: Angot, Elodie, et al.
Publicado: (2012)

Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits
por: Lebedev, Alexander V., et al.
Publicado: (2014)

A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy
por: Orrù, Christina D., et al.
Publicado: (2020)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Reward insensitivity is associated with dopaminergic deficit in rapid eye movement sleep behaviour disorder
por: Barber, Thomas R, et al.
Publicado: (2022)

Amplification of Tau Fibrils from Minute Quantities of Seeds
por: Meyer, Virginia, et al.
Publicado: (2014)

Thermal adaptation of mesophilic and thermophilic FtsZ assembly by modulation of the critical concentration
por: Concha-Marambio, Luis, et al.
Publicado: (2017)

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
por: Kazmi, Hiba, et al.
Publicado: (2021)

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
por: Frey, Bryan, et al.
Publicado: (2023)

Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8‐deficient mice
por: Bosse, Kelly E., et al.
Publicado: (2015)

Dopaminergic modulation of default mode network brain functional connectivity in attention deficit hyperactivity disorder
por: Silberstein, Richard B., et al.
Publicado: (2016)

Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study
por: Gajos, Agata, et al.
Publicado: (2017)

Dopaminergic Modulation of Goal-Directed Behavior in a Rodent Model of Attention-Deficit/Hyperactivity Disorder
por: Natsheh, Joman Y., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r2pqe19c3gt11i5edbm1aroaam